Patients with the most advanced rheumatoid arthritis remain with Th1 systemic defects after TNF inhibitors treatment despite clinical improvement
暂无分享,去创建一个
L. Karabon | I. Frydecka | P. Wiland | J. Świerkot | J. Szechiński | A. Partyka | A. Kosmaczewska | A. Chrobak | L. Ciszak | A. Szteblich